Literature DB >> 15305081

Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.

Kostas N Fountas1, Effie Z Kapsalaki, Robert L Vogel, Ioannis Fezoulidis, Joe Sam Robinson, Efstathios D Gotsis.   

Abstract

BACKGROUND: Proton magnetic resonance spectroscopy (1H MRS) constitutes a promising modality to assess intracranial pathology. We present our experience using this method in grading solid brain astrocytomas.
MATERIAL AND METHODS: Using a 1.5-Tesla MRI unit, 71 patients with the radiographic diagnosis of astrocytoma were examined. Water-suppressed single-voxel 1H MRS was employed in all of our patients. The concentrations of choline (Cho), N-acetyl-aspartate (NAA), phosphocreatine-creatine (Pcr-Cr), myo-inositol (MI), lactate (Lac), lipids (Lip) as well as the metabolite ratios of Cho/Pcr-Cr, NAA/PCr-Cr and NAA/Cho were calculated. An appropriate surgical biopsy was performed. Standard pathology examination was employed in a double-blinded fashion.
RESULTS: An increased concentration of Cho and decreased concentrations of Pcr-Cr and NAA were detected. The concentrations of Lac, Lip and MI varied inconsistently, even among tumors of the same histologic grade. The Cho/Pcr-Cr ratio was calculated. This ratio was found to be 2.15 +/- 0.26 in 27 patients with astrocytomas grade I and II, 2.78 +/- 0.09 in 18 patients with grade III, and 5.40 +/- 0.16 in 26 patients with grade IV. DISCUSSION: The increased concentration of Cho is due to the increased cellularity and a relatively increased number of membranous structures in highly malignant tumors. In abnormal anaerobic metabolic tumor states there is relatively less phosphorylization of creatine. By using the Cho/Pcr-Cr ratio the concomitant effects of structural and metabolic alteration can thereby be emphasized for diagnostic advantage.
CONCLUSION: The Cho/Pcr-Cr is a very important and statistically significant marker (p = 0.043) determining the degree of intracranial astrocytoma malignancy. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305081     DOI: 10.1159/000077458

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  17 in total

Review 1.  A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors.

Authors:  W Hollingworth; L S Medina; R E Lenkinski; D K Shibata; B Bernal; D Zurakowski; B Comstock; J G Jarvik
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

Review 2.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 3.  The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.

Authors:  Qun Wang; Hui Zhang; JiaShu Zhang; Chen Wu; WeiJie Zhu; FangYe Li; XiaoLei Chen; BaiNan Xu
Journal:  Eur Radiol       Date:  2015-10-15       Impact factor: 5.315

Review 4.  Current Clinical Brain Tumor Imaging.

Authors:  Javier E Villanueva-Meyer; Marc C Mabray; Soonmee Cha
Journal:  Neurosurgery       Date:  2017-09-01       Impact factor: 4.654

5.  Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy.

Authors:  Fumiyuki Yamasaki; Junko Takaba; Megu Ohtaki; Nobukazu Abe; Yoshinori Kajiwara; Taiichi Saito; Hiroyuki Yoshioka; Seiji Hama; Tomohide Akimitsu; Kazuhiko Sugiyama; Kazunori Arita; Kaoru Kurisu
Journal:  Neurosurg Rev       Date:  2005-08-18       Impact factor: 3.042

Review 6.  Imaging biomarkers in primary brain tumours.

Authors:  Egesta Lopci; Ciro Franzese; Marco Grimaldi; Paolo Andrea Zucali; Pierina Navarria; Matteo Simonelli; Lorenzo Bello; Marta Scorsetti; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-18       Impact factor: 9.236

7.  The effect of paramagnetic contrast in choline peak in patients with glioblastoma multiforme might not be significant.

Authors:  E C Lima; M C G Otaduy; M Tsunemi; R Pincerato; E F Cardoso; S Rosemberg; P H Aguiar; G G Cerri; C C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-05       Impact factor: 3.825

8.  Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.

Authors:  Kai Zhang; Chuanfu Li; Ying Liu; Li Li; Xiangxing Ma; Xiangshui Meng; Dechao Feng
Journal:  Neuroradiology       Date:  2007-09-01       Impact factor: 2.804

9.  Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.

Authors:  Sanjeev Chawla; Seung-Cheol Lee; Suyash Mohan; Sumei Wang; MacLean Nasrallah; Arastoo Vossough; Jaroslaw Krejza; Elias R Melhem; S Ali Nabavizadeh
Journal:  Neuroradiol J       Date:  2019-05-03

10.  In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.

Authors:  Jun Chen; Shu-Lan Huang; Tao Li; Xi-Lan Chen
Journal:  Neuroradiology       Date:  2006-03-22       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.